BioSpace News Archive

MIRAMAR, Fla., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced call-in details for the upcoming investor conference call on Thursday February 13th 2020 at 11:00am AM Eastern time. The access information for the investor conference call is as follows: Domestic US/Canada – 1-877-830-2591 Direct Toll / International – 1-785-424-1738 Program Title: Generex Biotechnology Conference Call Conference ID – 9468 Agenda − 2019-nCOV

TORONTO, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) is pleased to announce that it has entered into a letter of intent, dated February 11, 2020 (the “LOI”) with Psilocin Pharma Corp. (“Psilocin”), an arm’s length party incorporated pursuant to the laws of the Province of Ontario. Pursuant to the terms of the LOI, Revive will acquire all of the issued and outstanding securities of Psilocin (the “Proposed Acquisition”) for an aggregate purchase price o

MIM Software Inc., a leading global provider of medical imaging software, announced today a collaboration with Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, that will provide patient-specific dosimetry of Yttrium-90 (Y-90) microspheres globally.

All consolidated entities revenues grew plus compared to prior year YONGIN, South Korea , Feb. 12, 2020 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited results for the year ended 31 December 2019 . Key Figures (1 ) Full Year 2019 (2 )

WorkFusion, a top provider of Intelligent Automation software, has just been recognized by HFS Research in its new “HFS Top Robotic Process Automation (RPA) Software Products 2020” report.

Feb. 12, 2020 14:00 UTC SALT LAKE CITY--( BUSINESS WIRE )-- PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced the pricing of an underwritten public offering of approximately 10,638,298 shares of its common stock and warrants to purchase up to 10,638,298 shares of its common stock. Each share of common stock is being sold together with a warrant to purchase one share of common stoc

Dr. Laurence Klotz M.D., FRCSC, CM, the Chief Medical Officer of miR Scientific LLC, will present the results of the recently completed Case-Control validation study of 1,436 patients consisting of 836 patients in a fully cross-validated training group and independent testing group of 600 patients

Feb. 12, 2020 14:00 UTC ACADIA to Host Conference Call and Webcast on Wednesday, February 26, 2020, at 5:00 p.m. Eastern Time SAN DIEGO--( BUSINESS WIRE )-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2019 financial results on Wednesday, February 26, 2020, after the close of the U.S. financial markets. ACADIA’s management team will also host a conference call and webcast on February 26, 2020, at 5:00 p.m. East

Feb. 12, 2020 14:05 UTC Novel MRI system is a breakthrough in patient accessibility and cost GUILFORD, Conn.--( BUSINESS WIRE )-- Hyperfine Research, Inc. announced today that it has received US Food & Drug Administration 510(k) clearance for the world’s first bedside Magnetic Resonance Imaging (MRI) system, clearing the way for device shipments this summer. The Hyperfine system is 20X lower cost, 35X lower power consumption, and 10X lower weight than today’s fixed conv

NEW YORK and SYDNEY , Feb. 12, 2020 /PRNewswire/ -- EnGeneIC Limited , a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targeted cyto-immunotherapy in cancer, today announced that the Company was featured in the publication InsightsCare